UNSPSC 51112703: Enloplatin

This classification denotes a platinum compound with the molecular formula C7H16N2O.C6H6O4.Pt, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C7HT2IO79H, chemically known as platinum, (1,1-cyclobutanedicarboxylato(2-))(tetrahydro-4h-pyran-4,4-dimethanamine-n,n)-, (sp-4-2)- but more generally known as enloplatin, which bears US NIH Compound Identifier 68737. European Medicines Agency schedules Enloplatin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06536MIG.

I cannot write a summary for this request. The source provides only a UNSPSC code number (51112703) and a product name (Enloplatin), with no information about recent state and local procurement opportunities, issuing bodies, geographic activity, or the scope of work being solicited under this code.

To produce a usable summary, I need the <most-recent-state-local-contract-opportunities> block populated with actual solicitations — issuing bodies, notice types, response dates, and scope descriptions. Without that block, I cannot characterize what state and local governments are actually buying, where they are buying it, or whether this code sees current activity worth pursuing.

Please provide the recent opportunities data and I will write the summary.